Which Therapy for Helicobacter pylori Infection?
作者信息
Graham David Y, Shiotani Akiko
出版信息
Gastroenterology. 2012 Jul;143(1):10-2. doi: 10.1053/j.gastro.2012.05.012. Epub 2012 May 18.
Abstract
摘要
相似文献
1
Which Therapy for Helicobacter pylori Infection?幽门螺杆菌感染该用哪种治疗方法？
Gastroenterology. 2012 Jul;143(1):10-2. doi: 10.1053/j.gastro.2012.05.012. Epub 2012 May 18.
2
Sequential therapy for Helicobacter pylori eradication: is levofloxacin better?幽门螺杆菌根除的序贯疗法：左氧氟沙星效果更佳？
Gut. 2011 Nov;60(11):1604; author reply 1605-6. doi: 10.1136/gut.2010.231233. Epub 2010 Dec 29.
3
Levofloxacin in first-line eradication regimens for Helicobacter pylori: better test antibiotic susceptibility before treating.左氧氟沙星用于幽门螺杆菌一线根除治疗方案：治疗前最好检测抗生素敏感性。
Gut. 2011 Nov;60(11):1605; author reply 1605-6. doi: 10.1136/gut.2010.233015. Epub 2010 Dec 29.
4
Novel agent for Helicobacter pylori infection management.用于幽门螺杆菌感染管理的新型药物。
Chin Med J (Engl). 2013 Dec;126(23):4535.
5
[Acid-related diseases. What is the current rescue treatment of choice for Helicobacter pylori: quadruple therapy (proton pump inhibitor, bismuth, tetracycline and metronidazole) or triple therapy with proton pump inhibitor, amoxicillin and levofloxacin?].[酸相关性疾病。幽门螺杆菌目前的首选挽救治疗方案是什么：四联疗法（质子泵抑制剂、铋剂、四环素和甲硝唑）还是质子泵抑制剂、阿莫西林和左氧氟沙星的三联疗法？]
Gastroenterol Hepatol. 2008 Jun-Jul;31(6):400-1. doi: 10.1157/13123612.
6
7
Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection.5 天左氧氟沙星三联疗法根除幽门螺杆菌感染的疗效。
Gastroenterology. 2012 Jul;143(1):55-61.e1; quize e13-4. doi: 10.1053/j.gastro.2012.03.043. Epub 2012 Apr 3.
8
Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia.对幽门螺杆菌阳性非溃疡性消化不良患者采用含左氧氟沙星的7天和14天一线治疗方案的比较。
Turk J Gastroenterol. 2010 Mar;21(1):12-6. doi: 10.4318/tjg.2010.0041.
9
[The efficacy of levofloxacin based triple therapy for Helicobacter pylori eradication].[基于左氧氟沙星的三联疗法根除幽门螺杆菌的疗效]
Korean J Gastroenterol. 2006 Jul;48(1):19-24.
10
[Efficacy of levofloxacin-based triple therapy as second-line Helicobacter pylori eradication].以左氧氟沙星为基础的三联疗法作为二线根除幽门螺杆菌的疗效
Korean J Gastroenterol. 2008 May;51(5):285-90.
引用本文的文献
1
Impact of previous metronidazole exposure on metronidazole-based second-line quadruple therapy for Helicobacter pylori infection.既往甲硝唑暴露对幽门螺杆菌感染基于甲硝唑的二线四联疗法的影响。
Korean J Intern Med. 2020 Sep;35(5):1094-1103. doi: 10.3904/kjim.2020.174. Epub 2020 Jul 31.
2
Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled Study.基于莫西沙星-右旋兰索拉唑的7天和14天三联疗法及益生菌补充剂根除泰国非溃疡性消化不良患者幽门螺杆菌的疗效：一项双盲随机安慰剂对照研究
Asian Pac J Cancer Prev. 2017 Oct 26;18(10):2839-2843. doi: 10.22034/APJCP.2017.18.10.2839.
3
First-line therapies for eradication: a critical reappraisal of updated guidelines.根除治疗的一线疗法：对更新指南的批判性重新评估。
Ann Gastroenterol. 2017;30(4):373-379. doi: 10.20524/aog.2017.0166. Epub 2017 Jun 1.
4
Eradication of Helicobacter pylori Infection.幽门螺杆菌感染的根除
Curr Gastroenterol Rep. 2016 Jul;18(7):33. doi: 10.1007/s11894-016-0509-x.
5
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA.在美国，幽门螺杆菌对克拉霉素耐药及治疗失败的情况很常见。
Dig Dis Sci. 2016 Aug;61(8):2373-2380. doi: 10.1007/s10620-016-4091-8. Epub 2016 Feb 29.
6
Review article: the global emergence of Helicobacter pylori antibiotic resistance.综述文章：幽门螺杆菌抗生素耐药性在全球的出现
Aliment Pharmacol Ther. 2016 Feb;43(4):514-33. doi: 10.1111/apt.13497. Epub 2015 Dec 23.
7
Antibiotic treatment for Helicobacter pylori: Is the end coming?幽门螺杆菌的抗生素治疗：终点将至？
World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):183-98. doi: 10.4292/wjgpt.v6.i4.183.
8
Kyoto global consensus report on Helicobacter pylori gastritis.《京都幽门螺杆菌胃炎全球共识报告》
Gut. 2015 Sep;64(9):1353-67. doi: 10.1136/gutjnl-2015-309252. Epub 2015 Jul 17.
9
Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacy.吡啶二氮杂卓胺类化合物是通过抑制谷氨酸消旋酶来抑制幽门螺杆菌生长的选择性治疗药物，但预计需要血浆中持续保持较高水平才能达到临床疗效。
Antimicrob Agents Chemother. 2015 Apr;59(4):2337-42. doi: 10.1128/AAC.04410-14. Epub 2015 Feb 2.
10
Therapy of Helicobacter pylori: present medley and future prospective.幽门螺杆菌的治疗：当前的混杂情况与未来展望
Biomed Res Int. 2014;2014:124607. doi: 10.1155/2014/124607. Epub 2014 Apr 1.
本文引用的文献
1
Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection.5 天左氧氟沙星三联疗法根除幽门螺杆菌感染的疗效。
Gastroenterology. 2012 Jul;143(1):55-61.e1; quize e13-4. doi: 10.1053/j.gastro.2012.03.043. Epub 2012 Apr 3.
2
Letter: the ethics of using inferior regimens in H. pylori randomised trials.信件：幽门螺杆菌随机试验中使用劣质方案的伦理学问题。
Aliment Pharmacol Ther. 2012 Apr;35(7):852-4; discussion 858. doi: 10.1111/j.1365-2036.2011.04944.x.
3
Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection.随机试验：埃索美拉唑、莫西沙星和阿莫西林二线或补救治疗幽门螺杆菌感染的 14 天与 7 天疗程比较。
Helicobacter. 2011 Dec;16(6):420-6. doi: 10.1111/j.1523-5378.2011.00867.x.
4
Helicobacter pylori therapy demystified.幽门螺杆菌治疗揭秘。
Helicobacter. 2011 Oct;16(5):343-5. doi: 10.1111/j.1523-5378.2011.00891.x.
5
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study.将双联阿莫西林加奥美拉唑根除幽门螺杆菌的疗程延长至 6 周：一项初步研究。
J Gastroenterol Hepatol. 2012 Jan;27(1):59-61. doi: 10.1111/j.1440-1746.2011.06876.x.
6
Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.改良序贯疗法：质子泵抑制剂和阿莫西林治疗 14 天，随后加用克拉霉素和甲硝唑进行 7 天的四联（混合）治疗。
Helicobacter. 2011 Apr;16(2):139-45. doi: 10.1111/j.1523-5378.2011.00828.x.
7
Understanding and appreciating sequential therapy for Helicobacter pylori eradication.理解和欣赏幽门螺杆菌根除的序贯疗法。
J Clin Gastroenterol. 2011 Apr;45(4):309-13. doi: 10.1097/MCG.0b013e31820ac05e.
8
Helicobacter pylori eradication therapy research: Ethical issues and description of results.幽门螺杆菌根除治疗研究：伦理问题和结果描述。
Clin Gastroenterol Hepatol. 2010 Dec;8(12):1032-6. doi: 10.1016/j.cgh.2010.07.002. Epub 2010 Jul 23.
9
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.莫西沙星和左氧氟沙星三联疗法作为幽门螺杆菌持续感染二线治疗的优势：一项荟萃分析。
Wien Klin Wochenschr. 2010 Jul;122(13-14):413-22. doi: 10.1007/s00508-010-1404-3. Epub 2010 Jul 16.
10
Helicobacter pylori treatment in the era of increasing antibiotic resistance.幽门螺杆菌在抗生素耐药时代的治疗。
Gut. 2010 Aug;59(8):1143-53. doi: 10.1136/gut.2009.192757. Epub 2010 Jun 4.
Zotero 插件